Roche Company plans to heal as many patients as possible from advanced NSCLC

Patients, who received innovative antidiabetic drugs, have a lower risk of gout compared to those who received modern antidiabetic drugs

Emergence Therapeutics is working on the clinical development of its lead candidate that targets nectin-4

CEPI and Gritstone bio have entered into a deal to develop a candidate for a vaccine against omicron

Scientists have found that the delta variant incubation period can be 3-5 days

Scientists believe that some parts of Psychotria insularum can be used in traditional pharmaceutical production

Infectious mononucleosis experience in childhood is now considered as a factor that increases the risk of multiple sclerosis